Qualitative investigation into a wearable system for chronic obstructive pulmonary disease : the stakeholders' perspective by Kayyali, Reem et al.
Qualitative investigation into a wearable
system for chronic obstructive
pulmonary disease: the stakeholders’
perspective
Reem Kayyali,1 Vilius Savickas,1 Martijn A Spruit,2 Evangelos Kaimakamis,3
Roshan Siva,4 Richard W Costello,5 John Chang,4 Barbara Pierscionek,1
Nikki Davies,4 Anouk W Vaes,2 Rita Paradiso,6 Nada Philip,1 Eleni Perantoni,4
Shona D’Arcy,5 Andreas Raptopoulos,7 Shereen Nabhani-Gebara1
To cite: Kayyali R,
Savickas V, Spruit MA, et al.
Qualitative investigation into a
wearable system for chronic
obstructive pulmonary
disease: the stakeholders’
perspective. BMJ Open
2016;6:e011657.
doi:10.1136/bmjopen-2016-
011657
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2016-011657).
Received 8 March 2016
Revised 23 May 2016
Accepted 17 June 2016
For numbered affiliations see
end of article.
Correspondence to
Dr Reem Kayyali;
r.kayyali@kingston.ac.uk
ABSTRACT
Objectives: To ascertain the stakeholders’ views and
devise recommendations for further stages of the
Wearable Sensing and Smart Cloud Computing for
Integrated Care to Chronic Obstructive Pulmonary
Disease (COPD) Patients with Co-morbidities
(WELCOME) system development. This system aims to
create a wearable vest to monitor physiological signals
for patients concerned incorporating an inhaler
adherence monitoring, weight, temperature, blood
pressure and glucose metres, and a mobile health
application for communication with healthcare
professionals (HCPs).
Design: A study of qualitative data derived from focus
groups and semistructured interviews.
Setting: 4 participating clinical sites in Greece, the UK,
Ireland and the Netherlands.
Participants: Purposive sampling was used to recruit
32 patients with COPD with heart failure, diabetes,
anxiety or depression, 27 informal carers and 23 HCPs
from 4 European Union (EU) countries for focus groups
and interviews.
Results: Most patients and HCPs described the
WELCOME system as ‘brilliant and creative’ and felt it
gave a sense of safety. Both users and HCPs agreed that
the duration and frequency of vest wear should be
individualised as should the mobile application functions.
The parameters and frequency of monitoring should be
personalised using a multidisciplinary approach. A ‘traffic
light’ alert system was proposed by HCPs for abnormal
results. Patients were happy to take actions in response.
Conclusions:WELCOME stakeholders provided
valuable views on the development of the system, which
should take into account patient’s individual
comorbidities, circumstances and concerns. This will
enable the development of the individualised system in
each member state concerned.
INTRODUCTION
Exacerbations of chronic obstructive pulmon-
ary disease (COPD) are major contributors
to healthcare expenses1 2 and cause distress
to patients and their families.3 4 One-third of
hospital COPD admissions could be pre-
vented by earlier diagnosis and manage-
ment.1 However, COPD is complicated by a
large number of comorbidities, such as
chronic heart failure (CHF),5 diabetes6 as
well as symptoms of anxiety and/or
depression.7 8
Strengths and limitations of this study
▪ The strengths of this study are the insights into
the individualisation of the system design that it
provides and the noting of any issues or con-
cerns that may need to be taken into account
during the Wearable Sensing and Smart Cloud
Computing for Integrated Care to Chronic
Obstructive Pulmonary Disease (COPD) Patients
with Co-morbidities (WELCOME) system
development.
▪ These findings have broad applicability and can
be extended to any telehealth and wearable
systems developed for chronic conditions
monitoring.
▪ Interviews with various stakeholders, including
the service users, their carers and healthcare
providers, were a strength as they allowed for tri-
angulation which added credibility to any themes
emerging from the study.
▪ Elderly patients over 80 years of age formed a
minority of service users interviewed and may
not have been representative of the demograph-
ics of the ageing COPD population.
▪ The study did not take into account the views of
tax payers and service commissioners, which
should be considered as part of the costing exer-
cise, and only one general practitioner (GP) was
involved in the interview phase even though GPs
might have to lead the system implementation in
primary care setting in some countries.
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Advanced information technologies have made the
functioning of multidisciplinary COPD management
teams more feasible in recent years.9 10 With patient tel-
emonitoring, results or symptoms are obtained, and ana-
lysed via a predetermined decision support system.11–13
This can include informing the patient about actions to
be taken or referring them to appropriate healthcare
professionals (HCPs).14–16
Wearable Sensing and Smart Cloud Computing for
Integrated Care to COPD Patients with Co-morbidities
(WELCOME) is an innovative European Union tele-
health project that aims to develop a wearable vest with
sensors for the monitoring of physiological signals using
cloud computing technology (ﬁgure 1). The system uses
a number of patient-held devices, such as a blood
glucose metre and an inhaler adherence monitoring
device to assess the patient’s inhaler technique. This is
accompanied by a patient support system through a
mobile phone application providing lifestyle advice,
mental health assessment and other functions.17 The
WELCOME project is currently in its third year.
The WELCOME system will be validated in patients
with COPD suffering from CHF, diabetes, anxiety or
depression in four countries: Greece, the UK, Ireland,
and the Netherlands. It is hypothesised that continuous
monitoring and detection of worsening events will lead
to improved care for patients with COPD and reduced
rate of hospital admissions.
The WELCOME system framework adopts a user-
centred approach. For a successful system design, user
requirements of key stakeholders from each of the valid-
ating countries were determined following focus groups
and interviews. The aim of this study was to conﬁrm the
current state of COPD care and determine the stake-
holders’ views about the overall telehealth system pro-
posed; the vest, the mobile application, the triage
service and potential monitoring parameters in order to
guide the system development in each participating
country.
MATERIALS AND METHODS
Study subjects and design
This study used a mixed-method approach eliciting per-
ceptions of stakeholders through focus groups and inter-
views. Phenomenology was selected as the main
methodological orientation for this study since it was
aimed at determining the perceptions of stakeholders
regarding the current COPD care and potential integra-
tion of technology.
Purposive sampling was used to recruit 32 patients
with COPD, 27 informal carers and 23 HCPs in four
countries (table 1, ﬁgure 2). Each participant was pro-
vided with an information sheet and asked to sign a
consent form prior to taking part in the study.
Nine patients refused to participate in the study due
to lack of interest (n=3), the unfamiliarity with research
procedures (n=2), the unwillingness to take part in a
group interview (n=2), the inability to attend the focus
group in the hospital setting (n=1) or lack of time
(n=1). None of the patients dropped out of the study.
Figure 1 A summary of components involved in WELCOME system to aid data collection for further processing, reporting and
appropriate action. For further information, see figure 3 below. BG, blood glucose; BP, blood pressure; HR, heart rate;
WELCOME, Wearable Sensing and Smart Cloud Computing for Integrated Care to Chronic Obstructive Pulmonary Disease
Patients with Co-morbidities.
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The sources of listed evidence complemented each
other allowing for triangulation to establish credibility
within and across stakeholders.
Methods (interview process)
The focus groups and interviews were conducted in cor-
responding clinical sites. A total of ﬁve interviewers were
involved (2 in the UK and 1 in each other country). All
interviewers were members of the WELCOME project
consortium and held appropriate research qualiﬁcations
or had advanced expertise in the subject area. All inter-
viewers had a virtual meeting whereby they discussed the
interview schedule and agreed with the methodology for
running the focus groups/interviews.
The intercultural harmonisation during the study was
ensured by having native speakers in each country con-
ducting the corresponding interviews and approving all
schedules following the English translation. Participants
were informed about the inclusion/exclusion criteria for
the study through participant information sheets which
were translated in different languages as appropriate.
With minor exceptions, interviewees did not have an
established working or patient–clinician relationship
with interviewers prior to study initiation.
Focus groups lasted ∼2 hours. Two short question-
naires relating to medication adherence were also given
to patients and carers to complete anonymously during
the focus groups. The one-on-one semistructured inter-
views for HCPs lasted ∼1 hour. All sessions were audio
recorded and subsequently transcribed and translated
into English.
Analyses
Thematic analysis was conducted in a manual constant
comparative manner enabled by deductive and inductive
processes. One member of the research team transcribed
Table 1 Demographics of the patients from four countries who took part in the focus groups
Nationality
Number of
patients
Sex Age group Comorbidities
M F 51–60 61–70 71–80 81–90 CHF T2DM Asthma HTN Dep. Anx. Ins.
British 10 7 3 3 2 4 1 3 2 3 3 5 2 1
Greek 7 6 1 1 3 3 0 3 2 0 2 3 2 1
Dutch 8 1 7 6 2 0 0 1 1 1 0 0 1 0
Irish 7 3 4 2 2 2 1 1 2 5 1 1 1 4
Total 32 17 15 12 9 9 2 8 7 9 6 9 6 6
Percentage of
total
NA 53.1 46.9 37.5 28.1 28.1 6.3 25.0 21.9 28.1 18.8 28.1 18.8 18.8
Anx., anxiety; CHF, chronic heart failure; Dep., depression; F, female; HTN, hypertension; Ins., insomnia; M, male; NA, not applicable; T2DM,
type 2 diabetes mellitus.
Figure 2 A flow chart depicting the preparation and data collection during the focus group sessions and semistructured
interviews conducted as part of the present study. COPD, chronic obstructive pulmonary disease; GP, general practitioner/family
doctor; HCPs, healthcare professionals.
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the data; however, two researchers conducted the analysis
including coding. These codes were later compared,
altered and modiﬁed during the consolidated analysis
based on the full picture of the data as ideas developed.
On the basis of these emergent codes, overarching
themes from these interviews and focus groups were iden-
tiﬁed to generate overall stakeholder needs and frame-
work recommendations. The themes derived from the
three groups of stakeholders in one country were com-
pared and contrasted with those from the other three
countries to enable the individualisation of the system for
each state during the future stages of development.
RESULTS
Current care and challenges
The level of satisfaction with current care varied
between patients and carers of the four countries
(table 2). UK patients/carers were generally happy with
the current level of care and appreciated the Hot
(urgent care) clinic which offered 24-hour personalised
care. However, together with the Irish respondents they
expected better communication between HCPs. This was
echoed by HCPs of both countries who felt they lacked
appropriately trained staff and resources.
Greek and Dutch patients/carers reported long
waiting times when accessing healthcare. According to
the Dutch patients, general practitioners (GPs) were not
able to tackle some of the problems independently
claiming that, in pulmonary clinics, the support was
better. Poor mental health was reported as a challenge
by all but the Dutch cohort.
A varying degree of non-adherence to medicines was
reported by patients and carers of all countries despite
the fact that a signiﬁcant number of patients obtained
support from their pharmacist, for example, regular
checks for inhaler technique in the Netherlands. A
number of reasons for this emerged, including health
beliefs, generic versus brand-name drug substitution,
desperation, ﬁnancial issues or forgetfulness. Poor
patient engagement in their own care and non-
adherence to lifestyle recommendations was also identi-
ﬁed as a challenge by HCPs in all countries.
Acceptance of concepts proposed
Most Dutch patients were sceptical about telehealth, had
mixed views about the WELCOME project or the
inhaler monitoring device and were cautious about the
vest (table 3). A few carers were also more cautious as
they thought the system would target people from spe-
ciﬁc age groups that were technology-naive.
Other cohorts of patients/carers were receptive to tel-
ehealth and thought it was creative and gave a feeling of
safety. The idea of the vest was well received.
WELCOME was seen as a system that could help
patients decide when to seek medical assistance, thus
reducing the necessity of patients having to travel to and
from the doctors. However, Dutch patients had concerns
about being constantly monitored.
The majority of non-Dutch respondents felt that the
inhaler monitoring device would be helpful in conﬁrm-
ing correct use. The Dutch postulated that such a device
might be a ‘superﬂuous addition’ and may only be
Table 2 A summary of current challenges reported by patients/carers involved in the study in all four countries; theme
expressed/accepted is indicated as ✓; if box empty, no opinion was expressed on the theme; for Irish and Dutch data:
brackets show by whom theme is expressed (patients and/or carers)
Challenges UK patients and carers
Greek patients
and carers
Dutch patients and
carers Irish patients and carers
Miscellaneous Various methods to
remember to take
medicines
Long waiting
times to get
medical help
Dissatisfaction with
patient education
Fragmented care Healthcare services and
communication between
HCPs
Communication between
HCPs
Adherence to medication ✓ ✓ ✓, inhalers especially
challenging
✓, inhalers especially
challenging
Many reasons for
patients’ non-adherence
to medication
✓ ✓ ✓ ✓
Patients’ poor mental
health
✓ ✓ ✓(carers)
Limited healthcare
resources for patients
✓ ✓ ✓, limited or delayed
access to resources and
care (carers)
Reported satisfaction
with
24-hour COPD care in
‘HOT’ clinic at the UK
research centre
Pulmonary clinic,
pharmacist, care for
diabetes and CHF
Secretion clearance
device
If no differentiation, then the theme is expressed only by patients, with no contribution from carers.
CHF, chronic heart failure; COPD, chronic obstructive pulmonary disease; HCPs, healthcare professionals.
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helpful at the start of treatment. The mobile application
was welcomed by all but UK patients.
All HCPs were overall receptive to the WELCOME
concepts, except two pulmonologists (Dutch and Irish)
who felt that ‘published results about telehealth have
been varied’ and that the system success depended on
patients’ training. A multidisciplinary effort in delivering
the system and providing patients’ training and advice
was sought by most HCPs.
The vest
No signiﬁcant patient/carer consensus was reached on
the duration of vest wear (ranging from daily to wearing
whenever unwell). Most respondents disagreed with con-
tinuous wear, as it may be too stressful for the patient.
The development of male/female versions of the vest
was favoured by UK and Greek patients (see ﬁgure 3 for
concept vest).
HCPs from all countries conformed with the fact that
the vest should be worn both indoor and outdoor, and
for a period of time both during day and night. They
agreed that the frequency and duration of wear should
be individualised taking into account factors such as
adherence, frequency of exacerbations and comorbid-
ities. All HCPs agreed that increased duration of wear
should be considered postexacerbation/hospitalisation,
during and postexercise.
HCPs proposed a number of different ways the bio-
signals’ sensors should be located in the vest. For respira-
tory sensors this ranged from four sensors per quadrant
Figure 3 The proposed concept vest and sensors for Wearable Sensing and Smart Cloud Computing for Integrated Care to
Chronic Obstructive Pulmonary Disease Patients with Co-morbidities (WELCOME) system. Acknowledgement Smartex s.r.l.
Table 3 A summary of acceptance of the concepts proposed by patients/carers of all four countries involved in the study;
theme expressed/accepted is indicated as ✓; theme not desired is indicated as ×; if box empty, no opinion was expressed on
the theme; For Irish and Dutch data: brackets show by whom theme is expressed (patients and/or carers)
Acceptance of the
overall concept of:
UK patients
and carers
Greek patients
and carers Dutch patients and carers Irish patients and carers
Telehealth ✓ ✓ Mixed (most: × and sceptical) ✓(Patients and carers)
WELCOME ✓ ✓ Patients mixed views, carers
✓
✓(Patients and carers)
The vest ✓ ✓ ✓ ✓
The inhaler monitoring
device
✓ ✓ Patients: mixed views (believe
their technique is correct),
carers ✓
✓(Patients and carers)
WELCOME
application
× ✓ ✓(Patients and carers) Patients and carers: ✓incl.
educational advice that the app
can provide
If no differentiation, then the theme is expressed only by patients, with no contribution from carers.
WELCOME, Wearable Sensing and Smart Cloud Computing for Integrated Care to Chronic Obstructive Pulmonary Disease Patients with
Co-morbidities.
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and matrix-like positioning to four sensors each for
basal and dorsal parts of the lungs or sensors arranged
in two matrices (left and right). HCPs agreed that the
classical 12-lead ECG might be suitable for cardiac moni-
toring together with sensors over the apex of the heart,
basal parts and heart valves (opinions varied).
Primary concerns related to the vest design and use
included its weight (patients/carers from all countries),
availability of sizes, safety, potential skin irritation, over-
heating and thickness of the material (patients/carers
from 2 countries each). Concerns about conﬁdentiality,
for example, whether the vest would record surrounding
sounds and location detection was raised by British
patients/carers.
Monitoring results and parameters
The majority of patients/carers agreed that a 24/7
manned triage service run by GPs or pulmonologists was
needed whereas HCPs were not as supportive of such a
service preferring a time-deﬁned, HCP-led service and
welcoming a small degree of automated triage
(ﬁgure 4). They also felt that abnormal results should
be sent to all HCPs involved.
Patients demanded access to the complete set of their
results, and apart from Dutch respondents, the general
consensus was to enable carers to have a similar degree
of access as patients. HCPs felt that patients/carers
should have limited access to graphically presented
results.
According to HCPs, the interpretation of results
should be individualised and based on local guidelines,
clinical practice and predetermined early warning
scoring system, for example, green/amber/red colour
alerts with relevant actions according to the results.
A variety of methods to alert the patients to abnormal
ﬁndings were proposed by patients/carers, with text
messages and emails being the most popular. Those with
access to email preferred this format and graphical rep-
resentation of results. Patients and carers wished to be
informed as soon as possible or at least within 24 hours
if it were urgent. In other cases, the desired frequency
of reports varied.
The format of communication between the triage and
relevant HCPs included emails, text messages, diagrams
or verbal prompts. Communication between different
parties should be individualised based on each patient’s
clinical status, ranging from once weekly to daily and
real-time.
Patients/carers were willing to take individual actions
in response to any alerts. Nevertheless, some carers
would prefer human intervention before their response.
HCPs generally agreed for patients to initiate certain
actions, such as taking extra medication, in response to
alerts. Both patients and HCPs asked for non-urgent
communications to include motivational or reassuring
feedback/messages.
All interviewed HCPs agreed that the parameters to be
monitored should be individualised based on individual
comorbidities (ﬁgure 5). HCPs referred to numerous
guidelines/tools that may be used for populating the
parameters and assisting in monitoring and decision-
making, such as the Modiﬁed Medical Research Council
Dyspnoea Scale. No consensus on monitoring frequency
was reached between HCPs.
Figure 4 A summary of concepts relating to result monitoring, result display and alerts for patients as well as HCPs derived
during WELCOME interviews and qualitative analysis. 24/7, 24 hours a day, 7 days a week; A&E, accident and emergency
department; App, application; GP, general practitioner; HCPs, healthcare professionals; WELCOME, Wearable Sensing and
Smart Cloud Computing for Integrated Care to Chronic Obstructive Pulmonary Disease Patients with Co-morbidities.
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WELCOME mobile phone application
Despite generally positive reception of the application,
some patients/carers as well as certain HCPs expressed
concerns based on patient age preventing adaptation to
new technology or resulting in fatigue.
A range of functions to be included, as part of the
mobile phone application, were proposed by HCPs,
patients and carers (ﬁgure 6). Patients/carers and HCPs
from Greece and the UK felt that it should incorporate
educational videos from reputable sources personalised
depending on patients’ comorbidities.
Patients/carers from all countries were interested in
the diet/nutrition function of the application. All but
the Dutch patients also wished for the physical activity
and stress management functions whereas the mood
and social network functions were positively appraised
by patients/carers from two countries each, namely the
UK/Ireland and the Netherlands/Ireland, respectively.
UK and Greek patients, and Irish patients/carers
wanted an additional feature to enable question and
answer sessions with HCPs, for example, GPs. The Greek
and Dutch patients/carers proposed reminder and diary
Figure 5 A range of monitoring parameters proposed by healthcare professionals interviewed, which might be included in the
WELCOME system and individualised according to patient’s comorbidities. CAT, chronic obstructive pulmonary disease (COPD)
assessment test; WELCOME, Wearable Sensing and Smart Cloud Computing for Integrated Care to COPD Patients with
Co-morbidities.
Figure 6 A range of functions proposed by healthcare professionals (HCPs) and patients/carers (Pts/Crs) of the four countries
to be included as part of the Wearable Sensing and Smart Cloud Computing for Integrated Care to Chronic Obstructive
Pulmonary Disease Patients with Co-morbidities (WELCOME) mobile application.
Kayyali R, et al. BMJ Open 2016;6:e011657. doi:10.1136/bmjopen-2016-011657 7
Open Access
group.bmj.com on September 1, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
functions that correlated with the proposals from HCPs.
The Greek carers suggested an integrated accelerometer
to automatically record the patient’s physical activity.
The majority of functions were welcomed by HCPs
from all countries who wished to be involved depending
on their specialty. Clinical guidelines should be used
and extra caution exercised when developing certain
applications, for example, secretion clearance due to
associated risks. HCPs also made suggestions to include:
sexual well-being, medication and panic management
functions, and a function to help detect behavioural
changes.
While UK and Greek patients were happy for carers to
be alerted about patients’ dyspnoea, the general consen-
sus was for carers not to have access to the functions of
the application. In contrast, HCPs felt the application
should be used jointly by patients and their carers
depending on needs, that is, from daily to weekly consid-
ering patients’ individual circumstances.
DISCUSSION
This thematic analysis provided an in depth view into
the current state of care in four EU member states along
with how the proposed WELCOME project could be
implemented to integrate care and improve outcomes in
patients with COPD. Even though these results consti-
tuted the backbone of the WELCOME system’s user
requirements, they can be extrapolated to aid the plan-
ning of potential technology-enabled care services.
With regards to current care received, one of the
important points raised by all patient/carer cohorts
centred on the challenges they face in current health-
care systems including fragmented care, lack of commu-
nication and long waiting times. Fragmented healthcare
has been previously identiﬁed as a potential issue in
several EU countries due to increasing morbidity and
associated costs.18–20 Since WELCOME offers an alterna-
tive approach to tackling such fragmentation by provid-
ing a virtual cloud-based dynamic network between
patients, carers and HCPs, it was well received by the
majority of the participants.
Non-adherence to treatment emerged as one of the
key themes, and some patients were very honest about
how often they had forgotten or chosen not to take
their prescribed medicines. Health beliefs are well docu-
mented in the literature and are known to inﬂuence the
adherence rates.21 It should be noted that patients inter-
viewed never discussed adherence issues with their HCP,
while HCPs interviewed were unaware of the existence
of such issues. This was not surprising as it is often
widely accepted that HCPs underestimate the incidence
of non-adherence among their patients.22
Poor inhaler techniques is a known reason for non-
adherence,23 and a number of methods have been pro-
posed to address this.24 The WELCOME system includes
an inhaler monitoring device aimed at improving
patient’s technique leading to better adherence. With
minor exceptions, the inhaler monitoring device pro-
posed was considered a positive feature by users and
HCPs. Information on inhaler technique and a
reminder to take medicines/inhalers were among the
proposed functions for the mobile application. Some of
the medication-related problems identiﬁed could be
tackled through appropriate patient education.25 This
has been reﬂected in the interviews with HCPs who
highlighted the importance of detailed educational ses-
sions to train the patients and their carers about the
WELCOME system.
Despite general acceptance of the WELCOME frame-
work, the Dutch cohort of users were generally less posi-
tive about the system or its concepts regardless of their
comparatively young age and familiarity with mobile
technologies. The main limiting factor of the proposed
vest was its comfort. Such concerns were expected from
patients with COPD who already suffered from symptom-
atic chest discomfort.26
The majority of patients did not own smartphones
and wanted to receive information via text messages.
This correlated well with concerns expressed by HCPs
about ability of patients to engage with the WELCOME
system or the mobile application. While such limitations
may need to be considered when recruiting participants
for the validation study, they should not constitute the
exclusion criteria. Most patients demonstrated their
enthusiasm about WELCOME regardless of the level of
IT skills. Similar to other studies,27 this suggests that
technology-naïve patients/carers should not be excluded
from opportunities to enhance their health using novel
technologies based on their lack of prior experience.
Instead, non-patient factors, such as poor mobile or
internet reception, or technical malfunctions, may need
to be considered and addressed as potential barriers to
system development.13
Most HCPs in this study welcomed the system,
however, with a deﬁned monitoring time. This contra-
dicts the literature that shows resistance from frontline
staff due to perceived additional workload that telemoni-
toring may introduce,28 a negative perceived impact on
clinician–patient relationship,29 or due to potentially
unclear beneﬁts of telemonitoring.13 The latter was only
expressed by two pulmonologists in this study.
The results show that an individualised frequency and
duration of vest wear and monitoring should be chosen
for each patient, particularly for patients with COPD
whose daily lifestyle is often affected by the disease
itself.30 This may also be inﬂuenced by factors such as
the history of exacerbations and the diagnosed disease
stage. Therefore, patients should be involved when the
schedule of self-monitoring is decided and should be
consulted at each stage of vest design.
Parameters’ monitoring and feedback brought up a
signiﬁcant amount of debate. While some patients and
most HCPs agreed for carers to have access to vital statis-
tics, others were quite reluctant due to the burden for
carers and/or lack of privacy. This was not unexpected
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since the relationships between patients with COPD and
carers are often complex.31 The suggestion might be for
carers’ access to the results to be personalised in agree-
ment with the patients.
In terms of alerts, HCPs felt that these also need to be
generated in an individualised fashion. Clinical teams
might thus consider using retrospective data from each
clinical site based on their patients in order to identify
the level of change/thresholds and to develop a ‘trafﬁc
light’-based algorithm to be used for alerts. A threshold
average (different for every parameter) will mark a
minor deviation from the personal baseline, whereas
other thresholds will mark major abnormalities.
Patients mostly preferred doctors to receive and
screen alerts, and wanted access to their results to view
their progress. However, some also wanted pharmacists,
physiotherapists and nurses to be responsible for man-
aging/checking their monitoring parameters, thus sug-
gesting that all HCPs should have access to data, as was
also emphasised by most HCPs interviewed.
Unless urgent, most patients and HCPs wanted to
receive results regularly and requested positive motiv-
ational or reassurance feedback. It has been reported
that the provision of such information may enhance
physical activity.32
The ability of patients with COPD to self-manage
exacerbations is known to improve quality of life and
reduce hospital admissions.33 WELCOME users were
happy to adhere to action plans based on alerts or auto-
mated advice; however, self-management advice should
be appropriately formulated in a language that is sensi-
tive to patients’ needs. Furthermore, HCP-led support
and education for service users is of paramount import-
ance, particularly at the start of system implementation
to ensure optimal uptake of self-management
strategies.34
Patients were less receptive to the smartphone applica-
tion. It might have been perceived as an add-on com-
pared with the vest, which may have been perceived as a
life-saving measure. Patient’s limited interaction with
technology was one factor that was highlighted as inﬂu-
encing their acceptance of the application. However,
other factors including socio-demographics,
health-related factors or level of education may have had
an inﬂuence.35 36
HCPs emphasised that the range of application func-
tions should offer patients a choice depending on their
needs without jeopardising their autonomy. HCPs from
all four countries asked for the environment (eg,
weather update) and medication adherence functions,
the latter ﬁtting well with adherence issues identiﬁed by
patients/carers.
Diet, physical activity, smoking cessation and mood
and stress management functions were preferred by
HCPs and patients/carers. It is known that as many as
20% of patients with COPD suffer from depression,37 38
but they do not always seek adequate help despite an
increased risk of related morbidity and mortality.38 39
Therefore, the WELCOME application will include a
tool to discretely assess mood while providing education
about its impact on health. Patients with COPD are
known to be relatively socially isolated with their condi-
tion,40 thus it was not surprising that patients/carers
requested the development of the social network
function.
Overall, HCPs, patients and carers were very receptive
to the WELCOME framework proposed and were happy
to engage in it constructively. A number of themes have
been derived during the interview process with a range
of stakeholders and have been developed into appropri-
ate recommendations through triangulation. Most
importantly, our study demonstrated the need to person-
alise and integrate different parts of the system: the vest,
the mobile application and various external devices.
This is particularly important in light of the literature
which shows that neither regular monitoring of physio-
logical signs (eg, oxygen saturations) nor patient-
submitted daily electronic reports can reduce the fre-
quency of COPD exacerbations alone.13
The recommendations presented in this paper will be
considered in the later stages of system development and
design. While the backbone of the system developed
should be based on the recommendations derived, the
speciﬁcations of the system will need to be adjusted to
each participating EU member state based on their indi-
vidual healthcare system and needs of the service users.
As part of this process, any output of the vest components
proposed (eg, ECG or oxygen saturations) should be
mapped using a predetermined algorithm ‘trafﬁc light’
system in a manner similar to that previously described.41
The cost-effectiveness and cost-utility of the system will
also have to be evaluated to determine the core compo-
nents needed (eg, the application functions) and the
extent of personalisation to meet the individual’s needs
while still remaining cost-effective.42 This needs to be
compared with structured systematic approaches43 or
simple face-to-face educational interventions44 which
may lead to beneﬁts similar to those of advanced
technologies.
The recommendations outlined should be interpreted
with caution due to the limited number of participants
interviewed (particularly elderly patients over 80 years of
age) and differences in the interview process between
the users and providers of healthcare services. The study
also did not take into account the views of tax payers
and service commissioners, which should be considered
as part of the costing exercise. In addition, only one GP
was involved in the interview phase despite the fact that
GPs might have to lead the system implementation in
primary care setting.
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